Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 14;12(1):e12075.
doi: 10.1002/dad2.12075. eCollection 2020.

Longitudinal assessment of dementia measures in Down syndrome

Affiliations

Longitudinal assessment of dementia measures in Down syndrome

Lisa Koehl et al. Alzheimers Dement (Amst). .

Abstract

Introduction: Early detection of dementia symptoms is critical in Down syndrome (DS) but complicated by clinical assessment barriers. The current study aimed to characterize cognitive and behavioral impairment using longitudinal trajectories comparing several measures of cognitive and behavioral functioning.

Methods: Measures included global cognitive status (Severe Impairment Battery [SIB]), motor praxis (Brief Praxis Test [BPT]), and clinical dementia informant ratings (Dementia Questionnaire for People with Learning Disabilities [DLD]). One-year reliability was assessed using a two-way mixed effect, consistency, single measurement intraclass correlation among non-demented participants. Longitudinal assessment of SIB, BPT, and DLD was completed using linear mixed effect models.

Results: One-year reliability (n = 52; 21 male) was moderate for DLD (0.69 to 0.75) and good for SIB (0.87) and BPT (0.80). Longitudinal analysis (n = 72) revealed significant age by diagnosis interactions for SIB (F(2, 115.02) = 6.06, P = .003), BPT (F(2, 85.59) = 4.56, P = .013), and DLD (F(2, 103.56) = 4.48, P = .014). SIB progression (PR) had a faster decline in performance versus no-dementia (ND) (t(159) = -2.87; P = .013). Dementia had a faster decline in BPT performance versus ND (t(112) = -2.46; P = .041). PR showed quickly progressing scores compared to ND (t(128) = -2.86; P = .014).

Discussion: Current measures demonstrated moderate to good reliability. Longitudinal analysis revealed that SIB, BPT, and DLD changed with age depending on diagnostic progression; no change rates were dependent on baseline cognition, indicating usefulness across a variety of severity levels in DS.

Keywords: Down syndrome; cognition; dementia; longitudinal.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

FIGURE 1
FIGURE 1
Predicted changes in primary outcome measures by age and progression status. A) BPT total score declined with increasing age at a greater rate among those who had dementia from baseline (DM) compared to those who remained non‐demented (ND); B) SIB total score declined with increasing age at a greater rate among those who progressed (PR) compared to those who remained non‐demented (ND); C) There were no significant differences in rates of DLD change between groups, but there was a main effect of group whereby the DM group had significantly higher DLD total scores than the ND and PR groups

References

    1. Zigman WB, Lott IT. Alzheimer's disease in Down syndrome: neurobiology and risk. Ment Retard Dev Disabil Res Rev 2007;13(3):237‐246. 10.1002/mrdd.20163 - DOI - PubMed
    1. Malamud N. Neuropathology of organic brain syndromes associated with aging In Aging and the Brain. Springer; 1972:63‐87.
    1. Noetzel M. Dementia in Down Syndrome In Morris JC, ed. Handbook of Dementing Illnesses. New York: Marcel Dekker, Ink; 1994:243‐264.
    1. Wisniewski K, Wisniewski H, Wen G. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985;17:278‐282. - PubMed
    1. Bush A, Beail N. Risk factors for dementia in people with down syndrome: issues in assessment and diagnosis. Am J Ment Retard 2004;109(2):83‐97. 10.1352/0895-8017(2004)109<83:RFFDIP>2.0.CO;2 - DOI - PubMed